Stock THERAVANCE INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Theravance Inc Nasdaq

Equities

US88338T1043

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Theravance Inc
Apr. 24 Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc.?s Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024 CI
Mar. 04 Armata Pharmaceuticals Secures $35 Million Credit Agreement From Innoviva Unit MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. INVA Stock
  4. Stock
  5. News Theravance Inc
  6. Official Publications